Altimmune received award from US DoD to fund phase 1/2 clinical trial of T-COVIDï¾™ in outpatients with early COVID-19
On Jun. 29, 2020, Altimmune announced it was awarded $4.7 million from the U.S. Army Medical Research &…
On Jun. 29, 2020, Altimmune announced it was awarded $4.7 million from the U.S. Army Medical Research &…
On Jun. 29, 2020, LabCorpï¾® announced that Covance, its drug development business, has deployed the Xcellerateï¾® COVID-19 solution…
On Jun. 26, 2020, more than 300 scientists and clinicians from the federal government, industry and academia published…
On Jun. 26, 2020, Vaxart announced that its oral COVID-19 vaccine had been selected to participate in a…
On Jun. 25, 2020, the University of Alberta (U of A) announced a study that will analyze thousands…
On Jun. 25, 2020, Vaxart announced it had signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow,…
On Jun. 25, 2020, LabCorpï¾® announced the launch of a new test that can be used to assess…
On Jun. 24, 2020, HHMI investigators reported that data from COVID-19 cases around the world suggest that the…
On Jun. 24, 2020, Symbiosis Pharmaceutical Services, an India-based specialist provider of pharmaceutical and vaccine development services, announced…
On Jun. 24, 2020, the University of Oxford that the COVID-19 National DiagnOstic Research and Evaluation Platform (CONDOR)…
On Jun. 24, 2020, iBio announced that IBM Watson Health has selected iBio to receive 18 months of…
On Jun. 24, 2020, a team of scientists at Texas A&M University announced it is working with iBio…
On Jun. 23, 2020, the FDA launched Project Patient Voice, an initiative of the FDAï¾’s Oncology Center of…
On Jun. 23, 2020, the NIH announced it had tested a モuniversal mosquito vaccineï¾” known as AGS-v. It…
On Jun. 23, 2020, more than 300 scientists and clinicians from the federal government, industry and academia published…
On Jun. 23, 2020, FibroGen announced the initiation of a randomized, double-blind, placebo-controlled Phase 2 Study investigating the…
On Jun. 23, 2020, scientists at Scripps Research reported taht some common strains of influenza have the potential…
On Jun. 22, 2020, Intravacc announced promising results of a preclinical study with its experimental whooping cough vaccine…
On Jun. 22, 2020, Catalent announced that it had signed an agreement with ViralClear Pharmaceuticals, a subsidiary of…
On Jun. 22, 2020, Pfizer announced the initiation of four phase 3 clinical trials within its current pipeline…
On Jun. 22, 2020, Taconic Biosciences announced an exclusive agreement with the University of Texas Medical Branch at…
On Jun. 19, 2020, GSK announced that a scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19…
On Jun. 19, 2020, Dynavax Technologies announced the first participants were dosed in the Phase 1 clinical trial…
On Jun. 19, 2020, the COVID-19 pandemic in New York City caused a surge in out-of-hospital cardiac arrests…
On Jun. 18, 2020, the FDA announced participation in the COVID-19 Diagnostics Evidence Accelerator, a multi-stakeholder collaborative project…
On Jun. 18, 2020, Tonix Pharmaceuticals announced an expansion of its strategic collaboration with Southern Research to include…
On Jun. 18, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine, in collaboration with…
On Jun. 17, 2020, HHMI investigators reported they had identified long-concealed hidden mutations within the genomes of 100…
On Jun. 17, 2020, DNA from uterine cells of women with endometriosis has different chemical modifications, compared to…
On Jun. 17, 2020, Bvlgari, the Italian luxury brand, announced plans to support research into COVID-19 and vaccine…